Reticular basement membrane thickening in airways of lung transplant recipients is not affected by inhaled corticosteroids
- 1 December 2004
- journal article
- research article
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 34 (12), 1905-1909
- https://doi.org/10.1111/j.1365-2222.2004.02121.x
Abstract
Chronic rejection is a major problem for all lung transplant programmes, which is functionally manifested by fixed airflow limitation, Bronchiolitis Obliterans Syndrome (BOS). The inclusion of a Pre-BOS category, BOS(0 approximately p), in newly revised guidelines, recognizes the potential importance of early changes. We have previously demonstrated reticular basement membrane (Rbm) thickening in clinically stable lung transplant recipients free from BOS. The present study extends this, testing the hypothesis that inhaled corticosteroid (ICS) therapy will lead to a decrease in Rbm thickness in lung transplant recipients. A parallel group, bronchoscopic intervention study of clinically stable lung allograft recipients, free from BOS, but with evidence of airway inflammation. Following baseline assessment of Rbm thickening, subjects were randomized to 3 months of either chlorofluorocarbon-driven beclomethasone diproprionate (BDP) 400 microg b.i.d., or a formulation designed to yield at least an equivalent dose, hydrofluoroalkane-driven BDP, 200 microg b.i.d. Three months treatment with a moderate dose of ICS, including a formulation designed for preferential small airway deposition, had no effect on Rbm thickening (13+/-3 vs. 14+/-5 microm post-ICS). Our data would suggest that airway remodelling can occur early in lung allografts and is not affected by moderate dose ICS therapy. Longitudinal studies are required to describe the pathophysiological processes involved in BOS, and specifically to elucidate potential relationships between airway remodelling, airflow obstruction and allograft failure.Keywords
This publication has 19 references indexed in Scilit:
- Increased Expression of p21waf Cyclin-Dependent Kinase Inhibitor in Asthmatic Bronchial EpitheliumAmerican Journal of Respiratory Cell and Molecular Biology, 2003
- Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthmaThorax, 2002
- Remodeling in Asthma and Chronic Obstructive Lung DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Reduced Airway Distensibility, Fixed Airflow Limitation, and Airway Wall Remodeling in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Inhaled Corticosteroids and the Treatment of Lymphocytic Bronchiolitis Following Lung TransplantationAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Effect of a Long-acting β2-Agonist over Three Months on Airway Wall Vascular Remodeling in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Invited Lecture: Activation of the Epithelial Mesenchymal Trophic Unit in the Pathogenesis of AsthmaInternational Archives of Allergy and Immunology, 2001
- Bronchiolitis Obliterans Syndrome in Heart-Lung Transplant Recipients: Diagnosis with Expiratory CTRadiology, 2001
- Endobronchial Biopsy and Bronchoalveolar Lavage in Stable Lung Transplant Recipients and Chronic RejectionAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Effects of Treatment on Airway Inflammation and Thickening of Basement Membrane Reticular Collagen in Asthma: A Quantitative Light and Electron Microscopic StudyAmerican Review of Respiratory Disease, 1992